Cubist Systematic Strategies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,102
| Closed | -$10.9K | – | 2853 |
|
|
2024
Q1 | $10.9K | Sell |
4,102
-8,425
| -67% | -$22.4K | ﹤0.01% | 2034 |
|
|
2023
Q4 | $29.7K | Sell |
12,527
-31,189
| -71% | -$73.9K | ﹤0.01% | 1907 |
|
|
2023
Q3 | $61.2K | Sell |
43,716
-67,196
| -61% | -$94.1K | ﹤0.01% | 1692 |
|
|
2023
Q2 | $336K | Buy |
+110,912
| New | +$336K | ﹤0.01% | 1518 |
|
|
2023
Q1 | – | Sell |
-18,386
| Closed | -$112K | – | 3415 |
|
|
2022
Q4 | $112K | Buy |
18,386
+8,071
| +78% | +$49.2K | ﹤0.01% | 2826 |
|
|
2022
Q3 | $123K | Buy |
+10,315
| New | +$123K | ﹤0.01% | 3158 |
|
|
2021
Q4 | – | Sell |
-7,361
| Closed | -$169K | – | 3696 |
|
|
2021
Q3 | $169K | Buy |
+7,361
| New | +$169K | ﹤0.01% | 2634 |
|